Vibliome Therapeutics
Eric Springman has over two decades of experience in the pharmaceutical industry, specializing in arthritis and fibrosis therapy. Eric began their career as a group leader at Arris / Axys Pharmaceuticals in 1995. In 1998, they became head of arthritis and fibrosis therapy at Roche Pharmaceuticals. In 2001, they moved to Locus Pharmaceuticals as head of discovery and development, where they stayed until 2009. Eric is currently a scientific advisor at Vibliome Therapeutics.
Eric Springman received a bachelor's degree in chemistry/biology from Florida Atlantic University. Eric then went on to get their doctor of philosophy (Ph.D.) in molecular biophysics from Florida State University. Lastly, they completed a postdoctoral fellowship in allergy and immunology/clinical pharmacology at Vanderbilt University School of Medicine.
This person is not in the org chart
This person is not in any offices
Vibliome Therapeutics
Vibliome Therapeutics, LLC, has developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity.